Advertisement
New Zealand markets close in 4 hours 15 minutes

  • NZX 50

    11,891.41
    -55.02 (-0.46%)
     

  • NZD/USD

    0.5963
    +0.0013 (+0.22%)
     

  • NZD/EUR

    0.5557
    +0.0017 (+0.31%)
     

  • ALL ORDS

    7,841.90
    -95.60 (-1.20%)
     

  • ASX 200

    7,582.00
    -101.00 (-1.31%)
     

  • OIL

    83.90
    +0.33 (+0.39%)
     

  • GOLD

    2,341.30
    -1.20 (-0.05%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    17,917.28
    -171.42 (-0.95%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • NIKKEI 225

    37,599.70
    -28.78 (-0.08%)
     

  • NZD/JPY

    92.7730
    +0.2770 (+0.30%)
     

Why Novo Nordisk Stock Is Falling Today

George Budwell, The Motley Fool
·2-min read
Why Novo Nordisk Stock Is Falling Today

Shares of the Danish pharma giant Novo Nordisk (NYSE: NVO) were down by 3.4% on elevated volume as of 1:14 p.m. ET Tuesday afternoon. The drugmaker's shares are falling in response to the strong mid-stage data for Pfizer's orally administered diabetes and weight loss drug, danuglipron, which were published yesterday in JAMA Network medical journal. Novo's shares have more than doubled in value over the prior two years, thanks to the breakout success of its type 2 diabetes and weight loss drug semaglutide.

Continue reading